Institut für Pharmazie, Freie Universität Berlin, Königin-Luise-Str. 2+4, 14195, Berlin (Dahlem), Germany.
Naunyn Schmiedebergs Arch Pharmacol. 2010 Dec;382(5-6):487-97. doi: 10.1007/s00210-010-0564-z. Epub 2010 Sep 24.
The isolated rat tail artery (RTA) represents an in vitro model of the cutaneous circulation. We have characterised the postjunctional α(2)-adrenoceptor subtype mediating vasoconstriction to the α(2)-adrenoceptor (α(2)-AR) agonist UK14304 in RTA. In non-precontracted arterial rings at 32°C, a physiological temperature for the RTA, UK14304 elicited only slight contractions which were markedly enhanced after precontraction with serotonin (5-HT; 10-50 nM). Under the condition of elevated vascular tone, the contractile UK14304 response was competitively antagonised by MK912 (pA(2) = 10.05 ± 0.07), rauwolscine (pA(2) = 8.82 ± 0.06), yohimbine (pA(2) = 8.45 ± 0.04), WB4101 (pA(2) = 8.05 ± 0.05), BRL44408 (pA(2) = 7.20 ± 0.04), ARC239 (pA(2) = 6.90 ± 0.05) and prazosin (pA(2) = 6.80 ± 0.05). Schild regressions were linear and had slopes of unity. Affinities (pA(2)) for MK912, rauwolscine, yohimbine and WB41104 were in the same range as binding data (pK(D)) for these drugs at α(2C)-ARs of rat cerebral cortex. In addition, the presence of α(2C)-ARs was confirmed by Western blotting. In experiments to study the influence of temperature on vasoreactivity, UK14304-induced contractions did not differ at 37°C, 32°C or 27°C and were similarly blocked by rauwolscine (apparent pA(2) = 8.73-8.90). After rapid cooling (from 37°C to 27°C), the maximal UK14304 response was enhanced only in precontracted arteries; antagonism by rauwolscine was the same before and after cooling (apparent pA(2) = 8.80-8.90). The enhancement of the maximal UK14304 response was abolished by rewarming to 37°C. It is concluded that α(2C)-ARs predominantly mediated vasoconstriction in RTAs at any temperature tested. Since α(2C)-ARs may be involved in Raynaud's phenomenon, the isolated RTA represents a convenient in vitro bioassay to test novel compounds for the treatment of this syndrome.
分离的大鼠尾动脉(RTA)代表皮肤循环的体外模型。我们已经描述了介导大鼠尾动脉中 α(2)-肾上腺素能受体激动剂 UK14304 血管收缩的突触后 α(2)-肾上腺素受体(α(2)-AR)亚型。在 32°C(RTA 的生理温度)的非预收缩动脉环中,UK14304 仅引起轻微收缩,而在与 5-羟色胺(5-HT;10-50 nM)预收缩后,这种收缩明显增强。在血管张力升高的情况下,MK912(pA(2)= 10.05 ± 0.07)、rauwolscine(pA(2)= 8.82 ± 0.06)、育亨宾(pA(2)= 8.45 ± 0.04)、WB4101(pA(2)= 8.05 ± 0.05)、BRL44408(pA(2)= 7.20 ± 0.04)、ARC239(pA(2)= 6.90 ± 0.05)和哌唑嗪(pA(2)= 6.80 ± 0.05)竞争性拮抗可激动的 UK14304 反应。Schild 回归线是线性的,斜率为 1。MK912、rauwolscine、育亨宾和 WB41104 的亲和力(pA(2))与这些药物在大鼠大脑皮质 α(2C)-AR 上的结合数据(pK(D))相同。此外,通过 Western blot 证实了 α(2C)-AR 的存在。在研究温度对血管反应性影响的实验中,UK14304 诱导的收缩在 37°C、32°C 或 27°C 时没有差异,并且 rauwolscine 同样可以阻断(表观 pA(2)= 8.73-8.90)。快速冷却(从 37°C 降至 27°C)后,仅在预收缩的动脉中增强 UK14304 的最大反应;冷却前后 rauwolscine 的拮抗作用相同(表观 pA(2)= 8.80-8.90)。UK14304 最大反应的增强在重新加热至 37°C 时被消除。结论是,在测试的任何温度下,α(2C)-AR 主要介导 RTA 的血管收缩。由于 α(2C)-AR 可能参与雷诺现象,因此分离的 RTA 代表一种方便的体外生物测定法,可用于测试治疗该综合征的新型化合物。